Top

Published in:

01-11-2014 | Review Article

Neural control of lower urinary tract and targets for pharmacological therapy

Authors: Maria Augusta T. Bortolini, Andreisa P. M. Bilhar, Rodrigo A. Castro

Published in: International Urogynecology Journal | Issue 11/2014

Abstract

Studies on the physiology and pharmacology of the lower urinary tract have brought new information and concepts about the complex neural control of micturition. There are many mechanisms, some proven and others not yet completely understood, in which pharmacological agents may act facilitating the filling, storage, and emptying of the bladder. This review describes the peripheral innervation and the main pathways involved in lower urinary tract control. It also presents potential targets for the treatment of voiding dysfunctions.

Elbadawi A (1996) Functional anatomy of the organs of micturition. Urol Clin N Am 23(2):177–210CrossRef

Chai TC, Steers WD (1996) Neurophysiology of micturition and continence. Urol Clin N Am 23(2):221–236CrossRef

Sugaya K et al (2005) Central nervous control of micturition and urine storage. J Smooth Muscle Res 3:117–132CrossRef

Au JLS et al (1991) Evidence of significant absorption of sodium salicylate from urinary bladder of rats. J Pharmacol Exp Ther 258:357–364PubMed

Fry CH, Chacko S, Wachter S, Kanai AJ, Takeda M, Young JS (2013) Cell biology. In: Abrams P, Cardozo L, Khoury S, Wein A (eds) Incontinence, 5th edn. Health Publications, Plymouth

Steers WD (1998) Physiology and pharmacology of the bladder and urethra. In: Walsh PC, Retik AB, Vaughan ED Jr, Wein AJ (eds), Campbell’s urology, 7th edn. Saunders, Philadelphia, pp 870–915

Sugaya K, de Groat WC (2000) Influence of temperature on activity of the isolated whole bladder preparation of neonatal and adult rats. Am J Physiol 278:R238–R246

Unger CA, Tunitsky-Bitton E, Muffly T, Barber MD (2014) Neuroanatomy, neurophysiology, and dysfunction of the female lower urinary tract: a review. Female Pelvic Med Reconstr Surg 20(2):65–75PubMedCrossRef

Girão MJBC et al (2002) Neurofisiologia da micção. In: Girão MJBC (ed) Cirurgia vaginal e uroginecologia, 2nd edn. Ed Artes Médicas, Porto Alegre, pp 13–20

10.

De Groat WC, Booth AM, Yoshimura N (1993) Neurophysiology of micturition and its modification in animals models of human disease. In: Maggi CA (ed): The autonomic nervous system. Nervous control of the urogenital system, vol 3, Harwood Academic, Chur, pp 227–289

11.

Ralevic V, Burnstock G (1998) Receptors for purines and pyrimidines. Pharmacol Rev 50:413–492PubMed

12.

Sugaya K et al (1988) Efferent and primary afferent neural pathways innervating the lower urinary tract of the cat. Nippon Hinyokika Gakkai Zasshi 79:68–887

13.

Andersson KE (1993) Pharmacology of lower urinary tract smooth muscle and penile erection tissues. Pharmacol Rev 45:253–308

14.

Andersson KE, Arner A (2004) Urinary bladder contraction and relaxation: physiology and pathophysiology. Physiol Rev 84:935–986PubMedCrossRef

15.

Morrison J, Birder L, Craggs M, De Groat WC, Downie J, Drake M, Fowler C, Thor K (2005) Neural control. Abrams P, Cardozo L, Khoury S, Wein A (eds) Incontinence. Health Publications, Jersey, pp 363–422

16.

Burnstock G (2001) Purinergic signaling in the lower urinary tract. Abbracchio MP, Williams M (eds) Handbook of experimental pharmacology. Springer, Berlin, pp 423–515

17.

Caulfield MP, Birdsall NJM (1998) International union of pharmacology. XVII. Classification of muscarinic acetylcholine receptors. Pharmacol Rev 50:279–290PubMed

18.

Matsui M, Motomura D, Karasawa H, Fujikawa T, Jiang J, Komiya Y, Takahashi S, Taketo MM (2000) Multiple functional defects in peripheral autonomic organs in mice lacking muscarinic acetylcholine receptor gene for the M3 subtype. Proc Natl Acad Sci U S A 97:9579–9584PubMedCrossRefPubMedCentral

19.

Matsui M, Motomura D, Fujikawa T, Jiang J, Takahashi S, Manabe T, Taketo MM (2002) Mice lacking M2 and M3 muscarinic acetylcholine receptors are devoid of cholinergic smooth muscle contractions but still viable. J Neurosci 22:10627–10632PubMed

20.

Bennett BC et al (1993) Role of nitric oxide in reflex urethral sphincter relaxation during micturition. Soc Neurosci Abstr 19:511

21.

Mattiasson A et al (1987) Interaction between adrenergic and cholinergic nerve terminals in the rabbit, cat and man. J Urol 137:1017–1019PubMed

22.

Thornburry KD et al (1992) Medication by nitric oxide of neurogenic relaxation in the bladder neck muscle in sheep. J Physiol Lond 451:133–144

23.

Andersson KE, Wein AJ (2004) Pharmacology of the lower urinary tract: basic for current and future treatments of urinary incontinence. Pharmacol Rev 56:581–631PubMedCrossRef

24.

Clemens JQ (2010) Basic bladder neurophysiology. Urol Clin N Am 37:487–494CrossRef

25.

Takeda M, Obara K, Mizusawa T, Tomita Y, Arai K, Tsutsui T et al (1999) Evidence for beta3-adrenoceptor subtypes in relaxation of the human urinary bladder detrusor: analysis by molecular biological and pharmacological methods. J Pharmacol Exp Ther 288(3):1367–1373PubMed

26.

Takeda H, Yamazaki Y, Akahane M, Igawa Y, Ajisawa Y, Nishizawa O (2000) Role of the beta (3)-adrenoceptor in urine storage in the rat: comparison between the selective beta (3)-adrenoceptor agonist, CL316, 243, and various smooth muscle relaxants. J Pharmacol Exp Ther 293(3):939–945PubMed

27.

Igawa Y, Aizawa N, Homma Y (2010) Beta3-adrenoceptor agonists: possible role in the treatment of overactive bladder. Korean J Urol 51(12):811–818PubMedCrossRefPubMedCentral

28.

De Groat WC, Booth AM (1993) Synaptic transmission in pelvic ganglia. The autonomic nervous system, vol 3. In: Maggi CA (ed) Nervous control of the urogenital system. Harwood Academic, London, pp 291–347

29.

Thor K, Morgan C, Nadelhaft I, Houston M, De Groat WC (1989) Organization of afferent and efferent pathways in the pudendal nerve of the female cat. J Comp Neurol 288:263–279PubMedCrossRef

30.

De Groat WC, Fraser MO, Yoshiyama M, Smerin S, Tai C, Chancellor MB, Yoshimura N, Roppolo JR (2001) Neural control of the urethra. Scand J Urol Nephrol 35 [Suppl 201]:35–43CrossRef

31.

Yoshimura N, De Groat WC (1997) Neural control of the lower urinary tract. Int J Urol 4:111–125PubMedCrossRef

32.

Gosling JA et al (1977) The autonomic innervation of the urethra of the human male and female bladder neck and proximal urethra. J Urol 118:302–305PubMed

33.

Elbadawi A, Atta MA (1985) Ultrastructural analysis of vesicourethral innervation: evidence for somatomotor plus autonomic innervation of the feline rhabdosphincter. Neurourol Urodyn 4:23–36CrossRef

34.

Kakizaki H et al (1986) Na electromyographic study of the urethral rhabdosphincter in normal and chronically rhizotomized cats. Analysis of electrical potentials evoked by sympathetic and parasympathetic ganglia of the cat. In: Hanin I (ed) Dynamics of cholinergic function. Plenum Press, New York, pp 1057–1066

35.

Maggi CA (1993) The dual, sensory and efferent function of the capsaicin-sensitive primary sensory neurons in the urinary bladder and urethra. In: Maggi CA (ed) Nervous control of the urogenital system. Harwood Academic, London pp 383–422

36.

Morrison JFB (1999) The activation of bladder wall afferent nerves. Exp Physiol 84:131–136PubMed

37.

Pinna C et al (1999) Prostaglandin-release impairment in the bladder epithelium of streptozotocin-induced diabetic rats. Eur J Pharmacol 388:267–273CrossRef

38.

Downie JW, Karmazyn M (1984) Mechanical trauma to bladder epithelium liberates prostanoids which modulate neurotransmission in rabbit detrusor muscle. J Pharmacol Exp Ther 230:445–449PubMed

39.

Chuang Y, Fraser MO, Yu Y, Chancellor MB, De Groat WC, Yoshimura N (2001) The role of bladder afferent pathways in the bladder hyperactivity induced by intravesical administration of nerve growth factor. J Urol 165:975–979PubMedCrossRef

40.

Rong W, Spyer KM, Burnstock G (2002) Activation and sensitization of low and high threshold afferent fibres mediated by P2X receptors in the mouse urinary bladder. J Physiol Lond 541:591–600PubMedCrossRefPubMedCentral

41.

Andersson KE, Appell R, Awad S, Chapple C, Drutz H, Fourcroy J, Finkbeiner AE, Haab F, Wein A (2002) Pharmacological treatment of urinary incontinence. In: Khoury S, Wein A (eds) Incontinence, 1st international consultation on incontinence. Plymbridge, Plymouth, pp 479–512

42.

Keast JR, De Groat WC (1992) Segmental distribution and peptide content of primary afferent neurons innervating the urogenital organs and colon of male rats. J Comp Neurol 319:615–623PubMedCrossRef

43.

Christianson JA, Liang R, Davis BM, Fraser MO, Pezzone MA (2004) Retrograde labeling of urinary bladder and distal colonic afferents: a potential role of dichotomizing afferents in the overlap of chronic pelvic pain disorders. Gastroenterology 126:A115

44.

Pezzone MA, Liang R, Fraser MO (2005) A model of neural cross-talk and irritation in the pelvis: implications for the overlap of chronic pelvic pain disorders. Gastroenterology 128:1953–1964PubMedCrossRef

45.

Gupta SK, Sathyan G (1999) Pharmacokinetics of an oral once-a-day controlled-release oxybutynin formulation compared with immediate-release oxybutynin. J Clin Pharmacol 39:289–296PubMed

46.

Chancellor MB, Yoshimura N (2002) V. Physiology and pharmacology of the bladder and urethra. In: Walsh, PC, Retik AB, Vaughan ED Jr, Wein AJ (eds) Campbell’s urology, vol 2, 8th edn. Saunders, Philadelphia, pp 831–886

47.

Chapple CR, Yamanishi T, Chess-Williams R (2002) Muscarinic receptor subtypes and management of the overactive bladder. Urology 60:82–88PubMedCrossRef

48.

Yoshimura N, Chancellor MB (2002) Current and future pharmacological treatment for overactive bladder. J Urol 168:1897–1913PubMedCrossRef

49.

Levin RM et al (1986) Functional effects of the purinergic innervation of the rabbit urinary bladder. J Pharmacol Exp Ther 236:1327–1332

50.

Gibson SJ et al (1986) A VIP/PHI pathways links urinary bladder and sacral spinal cord. Peptides 7 [Suppl 1]:205–219PubMedCrossRef

51.

De Groat WC et al (1983) Role of neuropeptides in the sacral autonomic reflex pathways of the cat. J Auton Nerv Syst 7:339–350PubMedCrossRef

52.

Smith CP, Chancellor MB (2004) Emerging role of botulinum toxin in the treatment of voiding dysfunction. J Urol 171:2128–2137PubMedCrossRef

53.

Schurch B, De Seze M, Denys P et al (2005) Botulinum toxin type A is a safe and effective treatment for neurogenic urinary incontinence: results of a single treatment, randomized, placebo controlled 6-month study. J Urol 174:196–200PubMedCrossRef

54.

Smith CP, Boone TB, De Groat WC, Chancellor MB, Somogyi GT (2003) Effect of stimulation intensity and botulinum toxin isoform on rat bladder strip contractions. Brain Res Bull 61:165–171PubMedCrossRef

55.

Smith CP, Franks ME, Mcneil BK, Ghosh R, De Groat WC, Chancellor MB, Somogyi GT (2003) Effect of botulinum toxin A on the autonomic nervous system of the rat lower urinary tract. J Urol 169:1896–1900PubMedCrossRef

56.

Khera M, Somogyi GT, Kiss S, Boone TB, Smith CP (2004) Botulinum toxin A inhibits ATP release from bladder urothelium after chronic spinal cord injury. Neurochem Int 45:987–993PubMedCrossRef

57.

Barrick S, De Groat WC, Birder LA (2004) Regulation of chemical and mechanical-evoked ATP release from urinary bladder urothelium by botulinum toxin A. Soc Neurosci 541:5

58.

Chuang YC, Yoshimura N, Huang CC, Chiang PH, Chancellor MB (2004) Intravesical botulinum toxin a administration produces analgesia against acetic acid induced bladder pain responses in rats. J Urol 172:1529–1532PubMedCrossRef

59.

Vemulakonda VM, Somogyi GT, Kiss S, Salas NA, Boone TB, Smith CP (2005) Inhibitory effect of intravesically applied botulinum toxin a in chronic bladder inflammation. J Urol 173:621–624PubMedCrossRef

60.

Prieto D et al (1989) Distribution and density of neuropeptide Y immunoreactive nerve fibers and cells in the horse urinary bladder. J Auton Nerv Syst 27:173–180PubMedCrossRef

61.

Zoubek J et al (1993) A comparison of inhibitory effects of neuropeptide Y on rat urinary bladder, urethra and vas deferens. Am J Physiol 265:R537–R543PubMed

62.

Danuser H, Thor KB (1995) Inhibition of central sympathetic somatic outflow to the lower urinary tract of the cats by alpha-1 adrenergic receptor antagonist prazosin. J Urol 153:1308–1312PubMedCrossRef

63.

Jensen D (1981) Pharmacological studies of uninhibited neurogenic bladder: the influence of adrenergic excitatory and inhibitory drugs on the cystometrogram of neurological patients with normal and uninhibited bladder. Acta Neurol Scand 64:401–426PubMedCrossRef

64.

Nergardh A, Boreus LO (1972) Autonomic receptor function in the lower urinary tract of man and cat. Scand J Urol Nephrol 6:32–36PubMedCrossRef

65.

Nordling L (1983) Influence of the sympathetic nervous system on lower urinary tract in man. Neurourol Urodyn 2:3–45CrossRef

66.

Williams JH, Brading A (1992) Urethral sphincter: normal function and changes in disease. In: Daniel EE, Tomira T, Tschuida S, Watanabe M (eds) Sphincters. CRC Press, Boca Raton, pp 315–338

67.

Takasu T, Ukai M, Sato S, Matsui T, Nagase I, Maruyama T et al (2007) Effect of (R)-2-(2-aminothiazol-4-yl)-4′-{2-[(2-hydroxy-2phenylethyl) amino] ethyl} acetanilide (YM178), a novel selective beta3-adrenoceptor agonist, on bladder function. J Pharmacol Exp Ther 321(2):642–647PubMedCrossRef

68.

Suguita MAA, Girão MJBC, Simões MJ, Sartori MGF, Baracat EC, Rodrigues de Lima GA (2000) morphologic and morphometric study of the vesical mucosa and urethra of castrated female rats following estrogen and/or progestogen replacement. Clin Exp Obstet Gynecol 27:176–178PubMed

69.

Girão MJBC, Jármy-DiBella ZIK, Sartori MGF, Baracat EC, Lima GR (2001) Doppler velocimetry parameters of periurethral vessels in postmenopausal incontinent women receiving estrogen replacement. Int Urogynecol J 2:241–246

70.

Sartori MGF, Girão MJBC, de Jesus SM, Sartori JP, Baracat EC, Rodrigues de Lima G (2001) Quantitative evaluation of collagen and muscle fibers in the lower urinary tract of castrated and under-hormone replacement female rats. Clin Exp Obstet Gynecol 28:92–96PubMed

71.

De Deus JM, Girão MJ, Sartori MG et al (2003) Glycosaminoglycan profile in bladder and urethra of castrated rats treated with estrogen, progestogen, and raloxifene. Am J Obstet Gynecol 189(6):1654–1659PubMedCrossRef

72.

Robinson D, Cardozo LD (2003) The role of estrogens in female lower urinary tract dysfunction. Urology 62 [Suppl 4A]:45–51PubMedCrossRef

73.

Hendrix SL, Cochrane BB et al (2005) Effects of estrogen with and without progestin on urinary incontinence. JAMA 293(8):935–1001PubMedCrossRef

74.

Sairam K, Kulinskaya E, McNicholas TA et al (2002) Sildenafil influences lower urinary tract symptoms. BJU Int 90:836–839PubMedCrossRef

75.

McVary KT, Monnig W, Camps JL Jr et al (2007) Sildenafil citrate improves erectile function and urinary symptoms in men with erectile dysfunction and lower urinary tract symptoms associated with benign prostatic hyperplasia: a randomized, double-blind trial. J Urol 177:1071–1077PubMedCrossRef

76.

McVary KT, Roehrborn CG, Kaminetsky JC et al (2007) Tadalafil relieves lower urinary tract symptoms secondary to benign prostatic hyperplasia. J Urol 177:1401–1407PubMedCrossRef

77.

Stief CG, Porst H, Neuser D et al (2008) A randomised, placebo-controlled study to assess the efficacy of twice-daily vardenafil in the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia. Eur Urol 53:1236–1244PubMedCrossRef

78.

Janig W, Morrison JFB (1986) Functional properties of spinal visceral afferents supplying abdominal and pelvic organs, with special emphasis on visceral nociception. In: Cervero F, Morrison JFB (eds) Visceral sensation. Progress in brain research, vol 67. Elsevier, Amsterdam, pp 87–114CrossRef

79.

Hisamitsu T, de Groat WC (1984) Inhibitory effect of opioid peptides and morphine applied intrathecally and intracerebroventricularly on the micturition reflex in the cat. Brain Res 298:51–65PubMedCrossRef

80.

Booth AM et al (1985) Regulation of urinary bladder capacity by edogenous opioid peptides. J Urol 133:339–342PubMed

81.

Herman RM et al (1988) The effect of low dose intrathecal morphine on impaired micturition reflexes in human subjects with spinal cord lesions. Anesthesiology 69:313–318PubMedCrossRef

82.

Lecci A et al (1993) Evidence against a peripheral role of tachykinins in the initiation of micturition reflexes in the anesthetized rat. J Pharmacol Exp Ther 264:1327–1332PubMed

83.

Giuliani R et al (1993) Characterization of tachykinin neurokinin-2 receptor in the human urinary bladder by means of selective receptor antagonists and peptidase inhibitors. J Pharmacol Exp Ther 267:590–595PubMed

84.

Chancellor MB, Yoshimura MD (2004) Neurophysiology of stress urinary incontinence. Rev Urol 6 [Suppl 3]:S19–S28PubMedPubMedCentral

85.

Rajaofetra N et al (1992) Serotoninergic, noradrenergic and peptidergic innervation of Onuf’s nucleus of normal and transected spinal cords of baboons. J Comp Neurol 318:1–17PubMedCrossRef

86.

Norton PA et al (2002) Duloxetine versus placebo in the treatment of stress urinary incontinence. Am J Obstet Gynecol 187:40–48PubMedCrossRef

87.

Thor KB, Donatucci C (2004) Central nervous system control of the lower urinary tract: new pharmacological approaches to stress urinary incontinence in women. J Urol 172(1):27–33PubMedCrossRef

Title: Neural control of lower urinary tract and targets for pharmacological therapy
Authors: Maria Augusta T. Bortolini
Andreisa P. M. Bilhar
Rodrigo A. Castro
Publication date: 01-11-2014
Publisher: Springer London
Published in: International Urogynecology Journal / Issue 11/2014
Print ISSN: 0937-3462
Electronic ISSN: 1433-3023
DOI: https://doi.org/10.1007/s00192-014-2452-4

At a glance: The STEP trials

Springer Medicine

Neural control of lower urinary tract and targets for pharmacological therapy

Abstract

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 11/2014

Diagnosing levator avulsions after first delivery by tomographic ultrasound: reliability between observers from different centers

Left-sided sacrospinous ligament suspension for treating recurrent sigmoid neovagina prolapse

Treatment-seeking behaviour and social status of women with pelvic organ prolapse, 4th-degree obstetric tears, and obstetric fistula in western Uganda

Mechanical properties of pelvic soft tissue of young women and impact of aging

The effect of oral solifenacin succinate treatment on intraocular pressure: glaucoma paradox during overactive bladder treatment

Hysterectomy and urinary incontinence in postmenopausal women